Orion Portfolio Solutions LLC Lowers Stock Holdings in Aflac Incorporated (NYSE:AFL)

Orion Portfolio Solutions LLC cut its stake in shares of Aflac Incorporated (NYSE:AFL) by 4.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 66,474 shares of the financial services provider’s stock after selling 2,902 shares during the quarter. Orion Portfolio Solutions LLC’s holdings in Aflac were worth $6,876,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Private Trust Co. NA increased its position in Aflac by 1.3% during the 4th quarter. Private Trust Co. NA now owns 7,643 shares of the financial services provider’s stock valued at $791,000 after purchasing an additional 99 shares during the period. Phillips Wealth Planners LLC boosted its stake in shares of Aflac by 1.5% during the fourth quarter. Phillips Wealth Planners LLC now owns 6,553 shares of the financial services provider’s stock valued at $662,000 after purchasing an additional 100 shares in the last quarter. Raleigh Capital Management Inc. increased its holdings in Aflac by 23.2% during the fourth quarter. Raleigh Capital Management Inc. now owns 531 shares of the financial services provider’s stock valued at $55,000 after buying an additional 100 shares during the period. TKG Advisors LLC raised its stake in Aflac by 0.5% in the fourth quarter. TKG Advisors LLC now owns 21,255 shares of the financial services provider’s stock worth $2,230,000 after buying an additional 103 shares in the last quarter. Finally, Robertson Stephens Wealth Management LLC raised its stake in Aflac by 1.6% in the fourth quarter. Robertson Stephens Wealth Management LLC now owns 6,960 shares of the financial services provider’s stock worth $720,000 after buying an additional 107 shares in the last quarter. Institutional investors own 67.44% of the company’s stock.

Aflac Stock Performance

Shares of AFL stock opened at $109.71 on Friday. Aflac Incorporated has a 12-month low of $79.31 and a 12-month high of $115.50. The company has a market capitalization of $59.88 billion, a P/E ratio of 11.43, a P/E/G ratio of 3.24 and a beta of 0.93. The company has a current ratio of 0.10, a quick ratio of 0.08 and a debt-to-equity ratio of 0.29. The business’s 50 day moving average is $106.49 and its two-hundred day moving average is $107.66.

Aflac (NYSE:AFL) last released its earnings results on Wednesday, February 5th. The financial services provider reported $1.56 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.63 by ($0.07). Aflac had a return on equity of 16.20% and a net margin of 28.76%. Analysts expect that Aflac Incorporated will post 6.88 EPS for the current fiscal year.

Insider Activity at Aflac

In related news, Director Charles D. Lake II sold 29,802 shares of the stock in a transaction that occurred on Monday, March 10th. The stock was sold at an average price of $107.29, for a total value of $3,197,456.58. Following the completion of the transaction, the director now directly owns 49,962 shares in the company, valued at approximately $5,360,422.98. This represents a 37.36 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Joseph L. Moskowitz sold 1,000 shares of the business’s stock in a transaction dated Friday, March 7th. The shares were sold at an average price of $107.63, for a total transaction of $107,630.00. Following the completion of the sale, the director now owns 25,393 shares in the company, valued at approximately $2,733,048.59. This trade represents a 3.79 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 0.90% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have issued reports on the company. Barclays dropped their target price on Aflac from $98.00 to $95.00 and set an “underweight” rating on the stock in a research report on Friday, February 7th. Wells Fargo & Company cut their target price on Aflac from $104.00 to $102.00 and set an “equal weight” rating on the stock in a research note on Wednesday, February 19th. BMO Capital Markets assumed coverage on shares of Aflac in a research report on Thursday, January 23rd. They set a “market perform” rating and a $111.00 price target for the company. Piper Sandler cut their price objective on shares of Aflac from $122.00 to $118.00 and set an “overweight” rating on the stock in a research report on Friday, February 7th. Finally, JPMorgan Chase & Co. increased their price target on Aflac from $90.00 to $94.00 and gave the company a “neutral” rating in a research note on Tuesday, January 7th. Two research analysts have rated the stock with a sell rating, eleven have given a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat, Aflac currently has an average rating of “Hold” and an average target price of $103.36.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.